Dipivefrin | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
Dipivefrin | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Dipivefrin | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | |
Dipivefrin | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
Dipivefrin | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
Dipivefrin | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa01522 | Endocrine resistance | 1.69E-02 | 4 | P22694, P04049, P10415, Q13323 | PRKACB, RAF1, BCL2, BIK | More | |
Dipivefrin | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04014 | Ras signaling pathway | 9.62E-03 | 4 | P04049, Q15311, P0DP23, P17612 | RAF1, RALBP1, CALM1, PRKACA | More | |
Dipivefrin | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04022 | cGMP-PKG signaling pathway | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04024 | cAMP signaling pathway | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04062 | Chemokine signaling pathway | 3.98E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04071 | Sphingolipid signaling pathway | 3.35E-03 | 5 | P04049, P21453, Q9H228, P01375, Q13362 | RAF1, S1PR1, EDG8, TNF, PPP2R5C | More | |
Dipivefrin | hsa04072 | Phospholipase D signaling pathway | 2.82E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04080 | Neuroactive ligand-receptor interaction | 2.95E-04 | 8 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
Dipivefrin | hsa04114 | Oocyte meiosis | 2.15E-02 | 3 | P0DP23, P17612, Q13362 | CALM1, PRKACA, PPP2R5C | More | |
Dipivefrin | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Dipivefrin | hsa04140 | Autophagy - animal | 2.81E-02 | 4 | P04049, P22694, Q14643, P10415 | RAF1, PRKACB, ITPR1, BCL2 | More | |
Dipivefrin | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | |
Dipivefrin | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04210 | Apoptosis | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04217 | Necroptosis | 3.67E-04 | 8 | P01375, P23458, P48023, Q9NQC7, Q14765, Q99878, Q9H444, O75351 | TNF, JAK1, FASLG, CYLD, STAT4, H2AC14, CHMP4B, VPS4B | More | |
Dipivefrin | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.61E-03 | 6 | P07550, P17612, P22694, P18848, Q13362, P0DP23 | ADRB2, PRKACA, PRKACB, ATF4, PPP2R5C, CALM1 | More | |
Dipivefrin | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
Dipivefrin | hsa04360 | Axon guidance | 2.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04370 | VEGF signaling pathway | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04371 | Apelin signaling pathway | 2.65E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04540 | Gap junction | 5.06E-03 | 4 | P22694, P68371, P04049, Q14643 | PRKACB, TUBB2C, RAF1, ITPR1 | More | |
Dipivefrin | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | |
Dipivefrin | hsa04613 | Neutrophil extracellular trap formation | 2.65E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04650 | Natural killer cell mediated cytotoxicity | 2.93E-05 | 8 | P01375, P20963, P04049, Q13241, P26718, P26717, Q14953, P26715 | TNF, CD247, RAF1, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | |
Dipivefrin | hsa04657 | IL-17 signaling pathway | 2.41E-02 | 4 | P19875, P14780, P80188, P01375 | CXCL2, MMP9, LCN2, TNF | More | |
Dipivefrin | hsa04660 | T cell receptor signaling pathway | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04662 | B cell receptor signaling pathway | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04664 | Fc epsilon RI signaling pathway | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | |
Dipivefrin | hsa04713 | Circadian entrainment | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Dipivefrin | hsa04720 | Long-term potentiation | 5.58E-03 | 3 | P0DP23, P17612, P04049 | CALM1, PRKACA, RAF1 | More | |
Dipivefrin | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | |
Dipivefrin | hsa04725 | Cholinergic synapse | 3.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | |
Dipivefrin | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04728 | Dopaminergic synapse | 1.55E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
Dipivefrin | hsa04730 | Long-term depression | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04740 | Olfactory transduction | 4.53E-04 | 3 | Q9H255, P0DP23, P17612 | OR51E2, CALM1, PRKACA | More | |
Dipivefrin | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
Dipivefrin | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04910 | Insulin signaling pathway | 4.09E-03 | 3 | P0DP23, P17612, P04049 | CALM1, PRKACA, RAF1 | More | |
Dipivefrin | hsa04912 | GnRH signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04913 | Ovarian steroidogenesis | 1.27E-03 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
Dipivefrin | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04915 | Estrogen signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04916 | Melanogenesis | 2.88E-03 | 3 | P17612, P0DP23, P04049 | PRKACA, CALM1, RAF1 | More | |
Dipivefrin | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04919 | Thyroid hormone signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04921 | Oxytocin signaling pathway | 2.25E-03 | 4 | P0DP23, P17612, P04049, Q96RR4 | CALM1, PRKACA, RAF1, CAMKK2 | More | |
Dipivefrin | hsa04924 | Renin secretion | 9.81E-06 | 5 | P17612, P22694, P07550, Q14643, P0DP23 | PRKACA, PRKACB, ADRB2, ITPR1, CALM1 | More | |
Dipivefrin | hsa04926 | Relaxin signaling pathway | 6.24E-03 | 5 | P18848, P22694, P14780, P04049, P30679 | ATF4, PRKACB, MMP9, RAF1, GNA15 | More | |
Dipivefrin | hsa04927 | Cortisol synthesis and secretion | 1.27E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | |
Dipivefrin | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.75E-03 | 5 | Q14643, P22694, P23771, P04049, P10415 | ITPR1, PRKACB, GATA3, RAF1, BCL2 | More | |
Dipivefrin | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | |
Dipivefrin | hsa04934 | Cushing syndrome | 4.74E-02 | 3 | Q14643, P22694, P04628 | ITPR1, PRKACB, WNT1 | More | |
Dipivefrin | hsa04935 | Growth hormone synthesis, secretion and action | 2.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Dipivefrin | hsa04970 | Salivary secretion | 5.87E-05 | 6 | P07550, P17612, P22694, Q14643, P0DP23, P49913 | ADRB2, PRKACA, PRKACB, ITPR1, CALM1, CAMP | More | |
Dipivefrin | hsa04971 | Gastric acid secretion | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Dipivefrin | hsa04976 | Bile secretion | 2.20E-02 | 2 | P17612, Q14032 | PRKACA, BAAT | More | |
Dipivefrin | hsa05031 | Amphetamine addiction | 3.10E-03 | 5 | P0DP23, P17612, P22694, P18848, Q13547 | CALM1, PRKACA, PRKACB, ATF4, HDAC1 | More | |
Dipivefrin | hsa05034 | Alcoholism | 1.98E-03 | 4 | P17612, P0DP23, Q96RR4, P04049 | PRKACA, CALM1, CAMKK2, RAF1 | More | |
Dipivefrin | hsa05132 | Salmonella infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Dipivefrin | hsa05144 | Malaria | 1.91E-02 | 3 | P01375, P35443, P26718 | TNF, THBS4, KLRK1 | More | |
Dipivefrin | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | |
Dipivefrin | hsa05152 | Tuberculosis | 3.98E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | |
Dipivefrin | hsa05161 | Hepatitis B | 1.99E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05163 | Human cytomegalovirus infection | 4.98E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05170 | Human immunodeficiency virus 1 infection | 3.48E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 6 | P04049, P14780, P01375, P23588, Q13635, P22694 | RAF1, MMP9, TNF, EIF4B, PTCH1, PRKACB | More | |
Dipivefrin | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05212 | Pancreatic cancer | 2.37E-03 | 3 | P04049, Q15311, P23458 | RAF1, RALBP1, JAK1 | More | |
Dipivefrin | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05214 | Glioma | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05224 | Breast cancer | 1.49E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | |
Dipivefrin | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | |
Dipivefrin | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Dipivefrin | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | |